Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Hongxing Yan is active.

Publication


Featured researches published by Hongxing Yan.


Synthetic Communications | 2005

A Highly Convergent Synthesis of 2‐Phenyl Quinoline as Dual Antagonists for NK2 and NK3 Receptors

Hongxing Yan; Jeffrey K. Kerns; Qi Jin; Chongjie Zhu; Mary S. Barnette; James F. Callahan; Douglas W. P. Hay; Larry J. Jolivette; Mark A. Luttmann; Henry M. Sarau; Keith W. Ward; Katherine L. Widdowson; Zehong Wan

Abstract A novel and highly convergent synthesis leading to 2‐phenyl‐quinolines has been developed. As demonstrated in the preparation of 6‐fluoro‐3‐(3‐oxo‐piperazin‐1‐ylmethyl)‐2‐phenyl‐quinoline‐4‐carboxylic acid [(S)‐1‐cyclohexyl‐ethyl]‐amide (8), the method provides fascile access to this class of analogues via the common intermediate 7.


Journal of Medicinal Chemistry | 2009

Design, Synthesis, and Structure-Activity Relationship of Tropane Muscarinic Acetylcholine Receptor Antagonists

Dramane I. Laine; Zehong Wan; Hongxing Yan; Chongjie Zhu; Haibo Xie; Wei Fu; Jakob Busch-Petersen; Christopher E. Neipp; Roderick S. Davis; Katherine L. Widdowson; Frank E. Blaney; James E. Foley; Alicia M. Bacon; Edward F. Webb; Mark A. Luttmann; Miriam Burman; Henry M. Sarau; Michael Salmon; Michael R. Palovich; Kristen E. Belmonte

Novel tropane derivatives were characterized as muscarinic acetylcholine receptor antagonists (mAChRs). Through optimization of the structure-activity relationship around the tropane scaffold, the quaternary ammonium salt 34 was identified as a very potent M(3) mAChR antagonist. The compound was functionally active and displayed greater than 24 h duration of action in a mouse model of bronchoconstriction.


Bioorganic & Medicinal Chemistry Letters | 2009

Discovery of (3-endo)-3-(2-cyano-2,2-diphenylethyl)-8,8-dimethyl-8-azoniabicyclo[3.2.1 ]octane bromide as an efficacious inhaled muscarinic acetylcholine receptor antagonist for the treatment of COPD

Zehong Wan; Dramane I. Laine; Hongxing Yan; Chongjie Zhu; Katherine L. Widdowson; Peter T. Buckley; Miriam Burman; James J. Foley; Henry M. Sarau; Dulcie B. Schmidt; Edward F. Webb; Kristen E. Belmonte; Michael R. Palovich

Design and syntheses of a novel series of muscarinic antagonists are reported. These efforts have culminated in the discovery of (3-endo)-3-(2-cyano-2,2-diphenylethyl)-8,8-dimethyl-8-azoniabicyclo[3.2.1]octane bromide (4a) as a potent and pan-active muscarinic antagonist as well as a functionally active compound in a murine model of bronchoconstriction. The compound has also displayed pharmacokinetic characteristics suitable for inhaled delivery.


Bioorganic & Medicinal Chemistry Letters | 2012

Design, synthesis and structure–activity relationship of N-substituted tropane muscarinic acetylcholine receptor antagonists

Dramane I. Laine; Hongxing Yan; Haibo Xie; Roderick S. Davis; Jeremy Dufour; Katherine L. Widdowson; Michael R. Palovich; Zehong Wan; James J. Foley; Dulcie B. Schmidt; Gerald E. Hunsberger; Miriam Burman; Alicia M. Bacon; Edward F. Webb; Mark A. Luttmann; Michael Salmon; Henry M. Sarau; Sandra Umbrecht; Philip S. Landis; Brian Peck; Jakob Busch-Petersen

A novel series of N-substituted tropane derivatives was characterized as potent muscarinic acetylcholine receptor antagonists (mAChRs). Kinetic washout studies showed that the N-endosubstituted analog 24 displayed much slower reversibility at mAChRs than the methyl-substituted parent molecule darotropium. In addition, it was shown that this characteristic appeared to translate into enhanced which duration of action in a mouse model of bronchonstriction.


Journal of Medicinal Chemistry | 2016

Monoacidic Inhibitors of the Kelch-like ECH-Associated Protein 1: Nuclear Factor Erythroid 2-Related Factor 2 (KEAP1:NRF2) Protein–Protein Interaction with High Cell Potency Identified by Fragment-Based Discovery

Thomas G. Davies; William E. Wixted; Joseph E. Coyle; Charlotte Mary Griffiths-Jones; Keisha Hearn; Rachel McMenamin; David Norton; Sharna J. Rich; Caroline Richardson; Gordon Saxty; Henriette Willems; Alison Jo-Anne Woolford; Joshua E. Cottom; Jen-Pyng Kou; John Yonchuk; Heidi G. Feldser; Yolanda Sanchez; Joseph P. Foley; Brian Bolognese; Gregory A. Logan; Patricia L. Podolin; Hongxing Yan; James Francis Callahan; Tom D. Heightman; Jeffrey K. Kerns


Archive | 2009

Dual pharmacophores - pde4-muscarinic antagonistics

James Francis Callahan; Guoliang Lin; Zehong Wan; Hongxing Yan


Tetrahedron Letters | 2007

An improved and highly convergent synthesis of 4-substituted-pyrido[2,3-d]pyrimidin-7-ones

Hongxing Yan; Jeffrey Charles Boehm; Qi Jin; Jiri Kasparec; Huijie Li; Chongjie Zhu; Katherine L. Widdowson; James F. Callahan; Zehong Wan


Archive | 2006

Process for Preparing Pyrido[2,3-d]pyrimidin-7-one and 3,4-Dihydropyrimido[4,5-d]pyrimidin-2(1H)-one Derivatives

James F. Callahan; Jeffrey Charles Boehm; Zehong Wan; Hongxing Yan; Xichen Lin


Archive | 2004

M3 muscarinic acetylchoine receptor antagonists

Jakob Busch-Petersen; Anthony W. J. Cooper; Dramane I. Laine; Michael R. Palovich; Zehong Wan; Hongxing Yan; Chongjie Zhu


Tetrahedron Letters | 2009

Design and development of arrayable syntheses to accelerate SAR studies of pyridopyrimidinone and pyrimidopyrimidinone

Zehong Wan; Hongxing Yan; Ralph Hall; Xichen Lin; Stefano Livia; Tomasz Respondek; Katherine L. Widdowson; Chongjie Zhu; James F. Callahan

Collaboration


Dive into the Hongxing Yan's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge